“Stable CAD” Doesn’t Mean Zero Risk: Understanding Sudden Cardiac Death in Adults 61–74 With 3-Vessel Disease and Preserved LVEF

If you or a loved one has been told, “Your heart disease is stable,” it’s natural to feel relieved—and that sense of calm is important. But when it comes to stable CAD sudden cardiac death risk, especially in adults aged 61–74 with three-vessel coronary artery disease (CAD) and a left ventricular ejection fraction (LVEF) above 55%, that label doesn’t tell the whole story. For many people over 50, “stable” can mistakenly suggest safety from life-threatening events—like sudden cardiac death (SCD). In reality, stability refers to symptom control—not absence of underlying vulnerability. This misconception may lead to missed opportunities for personalized risk assessment and prevention.

Let’s gently unpack what “stable” really means—and how modern cardiology helps us look beyond labels to support long-term heart health with clarity and confidence.

Why “Stable CAD” Can Still Carry Sudden Cardiac Death Risk

“Stable CAD” describes patients who aren’t experiencing active angina, shortness of breath at rest, or recent heart attacks—but it doesn’t guarantee plaque stability. In fact, up to 70% of sudden cardiac deaths occur in people without prior major cardiac events. Even with preserved LVEF (>55%), subtle myocardial fibrosis (scarring), microvascular dysfunction, or vulnerable plaques—those prone to rupture—can trigger fatal arrhythmias like ventricular fibrillation. Additionally, 3-vessel disease increases the likelihood of ischemic substrate, especially during physical or emotional stress—even if symptoms are mild or well-managed with medication.

Importantly, LVEF alone isn’t enough to rule out risk. While an LVEF >55% reflects strong pumping function, it doesn’t capture electrical instability or regional scarring detectable only via advanced imaging like cardiac MRI or late gadolinium enhancement.

How to Accurately Assess Your Individual Risk

Modern risk stratification goes far beyond ejection fraction. Tools like the Seattle Heart Failure Model or the SCD-HeFT risk calculator incorporate clinical, imaging, and biomarker data—including NT-proBNP levels, QRS duration on ECG, history of non-sustained ventricular tachycardia, and even genetic markers in select cases. For adults 61–74 with multi-vessel CAD, newer guidelines recommend considering:

• Cardiac MRI to assess fibrosis burden
• Holter or event monitoring to detect silent arrhythmias
• Coronary CT angiography with plaque characterization (e.g., low-attenuation plaque, napkin-ring sign)

These tools help identify those who may benefit from closer follow-up—or preventive therapies like implantable cardioverter-defibrillators (ICDs) in select higher-risk individuals.

Who Should Pay Extra Attention?

Adults aged 61–74 with documented 3-vessel CAD—even if asymptomatic or “stable”—should discuss comprehensive risk assessment with their cardiologist, especially if they also have:

• A history of fainting (syncope) or near-fainting episodes
• Family history of sudden cardiac death before age 60
• Diabetes, chronic kidney disease, or elevated troponin levels
• Evidence of myocardial scar on imaging

Age itself matters: vascular stiffness and autonomic changes increase arrhythmic susceptibility after 60, independent of LVEF.

Practical Steps You Can Take Today

You don’t need to wait for your next appointment to support heart resilience:

✅ Prioritize consistent blood pressure control — aim for <130/80 mm Hg, as hypertension accelerates plaque progression and fibrosis.
✅ Stay physically active within your comfort zone, such as brisk walking 30 minutes most days—this supports rhythm stability and endothelial health.
✅ Follow a heart-smart diet: emphasize vegetables, whole grains, lean proteins, and healthy fats; limit sodium (<2,300 mg/day) and added sugars.
✅ Review medications regularly, especially beta-blockers or ACE inhibitors—these reduce both ischemic events and arrhythmic risk.
✅ Recognize subtle warning signs: unexplained fatigue, lightheadedness, palpitations that last more than a few seconds, or new shortness of breath during routine activity.

Tracking your blood pressure trends can help you and your doctor make better decisions. Consider keeping a daily log or using a monitoring tool to stay informed.

See your doctor promptly if you experience chest discomfort lasting more than a few minutes, sudden dizziness with exertion, or repeated unexplained episodes of near-fainting—even if your CAD has been labeled “stable.”

While no one can eliminate all risk, understanding your unique profile empowers thoughtful, proactive care. The goal isn’t fear—it’s informed partnership with your care team. If you're unsure, talking to your doctor is always a good idea.

FAQ

#### Does “stable CAD” mean I’m safe from sudden cardiac death?

Not necessarily. “Stable CAD” reflects symptom control—not absence of electrical or structural vulnerability. Adults 61–74 with 3-vessel disease and LVEF >55% still carry measurable stable CAD sudden cardiac death risk, particularly if other risk markers (like fibrosis or arrhythmia) are present.

#### What is the 5-year sudden cardiac death risk for someone with stable CAD and 3-vessel disease?

Among adults 61–74 with multivessel CAD and preserved LVEF, 5-year SCD risk ranges from 3–8%—higher than the general population and highly variable based on fibrosis, arrhythmia history, and biomarkers. Risk calculators help personalize this estimate.

#### Can stable CAD sudden cardiac death risk be reduced with lifestyle changes?

Yes—consistently managing BP, staying active, eating heart-healthy foods, and avoiding smoking all lower overall cardiovascular risk—including stable CAD sudden cardiac death risk. These steps support plaque stability and electrical resilience.

#### Is an ejection fraction over 55% enough to rule out sudden cardiac death risk?

No. LVEF measures pumping strength but not electrical stability or scar burden. Up to 40% of SCD cases occur in people with LVEF >50%. Additional testing (e.g., cardiac MRI, Holter monitoring) offers deeper insight.

#### Do I need an ICD if my CAD is stable and my heart pumps well?

Most people with stable CAD and LVEF >55% do not need an ICD—but certain high-risk features (e.g., inducible ventricular tachycardia, significant fibrosis, or prior syncope) may warrant discussion. Shared decision-making with your electrophysiologist is key.